Indonesia vs Sur: Number of new G2D leprosy cases
Indonesia
869
in 2024
Sur
1
in 2024
Indonesia rank
3rd
Sur rank
1st
Number of new G2D leprosy cases over time
- Indonesia
- Sur
How they compare
Indonesia currently reports 869 against 1 in Sur, a difference of 868.
That makes Indonesia's figure about 869.0 times Sur's.
Across all 13 years both countries report, Indonesia has been ahead every year.
Indonesia ranks 3rd and Sur ranks 1st of 161 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,478 | 1.5 | 1,477 | Indonesia |
| 2020s | 752.6 | 1.4 | 751.2 | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of new g2d leprosy cases, Indonesia or Sur?
- Indonesia, at 869 against 1 in Sur as of 2024.
- What is the difference in number of new g2d leprosy cases between Indonesia and Sur?
- 868, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Sur?
- 13 years are reported by both, from 2012 to 2024.
- How do Indonesia and Sur rank globally for number of new g2d leprosy cases?
- Indonesia ranks 3rd and Sur ranks 1st of 161 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of new G2D leprosy cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.